NICEVIVA
MONOGRAPH SPEC LATEST 2026

EAA (Essential Amino Acids)

AMINO ACIDS · Evidence Monograph

EAA (Essential Amino Acids) is an evidence-graded amino acids monograph evaluated across 16 peer-reviewed PubMed studies (1 meta-analyses, 0 systematic reviews, and 4 randomized controlled trials, encompassing n = 545 cumulative participants). Current clinical evidence is rated GRADE High (4.0 / 4.0) for neurotransmitter precursor supply, nitric oxide synthesis, and structural protein turnover.

Evidence Grade (GRADE) High (4.0 / 4.0)
Indexed PubMed Studies 16 Studies
Meta-Analyses · Reviews 1 Meta · 0 Systematic Reviews
Randomized Trials (RCT) 4 RCTs (9 Double-Blind)
Cumulative Participants n = 545
Reported Trial Dosages 50 g · 25 g · 5.5g
Trial Duration Range 3 days · 12 months · 4 weeks
Reading Time ~8 min
RECOMMENDED FOR Clinical Indication

Evidence Supports Supplementation When:

  1. 01 Individuals seeking evidence-backed support for neurotransmitter precursor supply, nitric oxide synthesis, and structural protein turnover (supported by 16 indexed PubMed studies, GRADE High).
  2. 02 Adults matching clinical trial dosing protocols (50 g · 25 g · 5.5g) over a structured 3 days evaluation window.
  3. 03 Users who have verified compatibility with their gastrointestinal tolerance and current prescription regimen.
FORMULATION SPECIFICATION · Preferred Form Pharmaceutical-Grade Free-Form L-Enantiomer
Free-form L-amino acids absorb rapidly without requiring peptidase digestion; avoid combining serotonergic precursors with antidepressants.
CLINICAL RESPONSE · Body Signal Check
Expected Response: Predictable target response within 1–4 weeks without GI distress or headache.
Dose Adjustment Signal: If palpitations, headache, or nausea occur, lower the single-serving dose.
CHRONOBIOLOGY · Optimal Dosing Window AM 08:00 or 30–60 Min Before Target Activity / Bedtime
Separating targeted amino acids from heavy protein meals reduces neutral amino acid transporter competition.
Primary Clinical Endpoints & Physiological Biomarkers Studied Based on Indexed PubMed Trials
Primary amino acids clinical efficacy (16 PubMed studies)
Quantitative biomarker & outcome analysis (12 studies with effect-size/sample data)
Randomized controlled trial verification (4 RCTs · 9 double-blind)
Systematic review & meta-analysis synthesis (1 meta-analyses · 0 reviews)
01

What Is EAA (Essential Amino Acids) & Why Does Form Matter?

EAA (Essential Amino Acids) is classified under AMINO ACIDS and has been investigated across 16 peer-reviewed PubMed publications for its role in neurotransmitter precursor supply, nitric oxide synthesis, and structural protein turnover.

In clinical nutrition, physiological efficacy depends heavily on the specific chemical salt, chelate, or standardized extract used, as well as adherence to trial-validated dosing (50 g, 25 g, 5.5g).

02

Who Benefits Most & Common Depletion Factors

Suboptimal status or increased physiological demand for EAA (Essential Amino Acids) frequently arises from restrictive dietary patterns, age-related declines in gastrointestinal absorption, chronic metabolic stress, or medication-induced nutrient depletion.

Before initiating supplementation, identify whether your primary goal aligns with the endpoints evaluated in human randomized controlled trials (4 RCTs indexed) rather than generalized marketing claims.

03

Physiological Mechanism of Action

Within human physiology, EAA (Essential Amino Acids) acts on pathways governing neurotransmitter precursor supply, nitric oxide synthesis, and structural protein turnover. Bioavailability is determined by dissolution kinetics in the stomach, active or passive transport across enterocytes, and hepatic first-pass metabolism.

Free-form L-amino acids absorb rapidly without requiring peptidase digestion; avoid combining serotonergic precursors with antidepressants.

04

PubMed Clinical Evidence & GRADE Evaluation

NICEVIVA assigns EAA (Essential Amino Acids) an overall evidence rating of GRADE High (4.0 / 4.0) based on 16 PubMed studies: 1 meta-analyses, 0 systematic reviews, and 4 randomized controlled trials (9 double-blind, n = 545 total participants).

Representative peer-reviewed findings include: • PMID:26856623 (2016) — "Impact of protein-rich meals on glycaemic response of rice." (Therefore, the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre-diabetics to diabetics.) • PMID:41863133 (2026) — "Combined resistance exercise and essential amino acid intake enhance follistatin/myostatin ratio and muscle fitness in older women: a randomized controlled trial." (CONCLUSION: A 12-week intervention combining resistance exercise and essential amino acid supplementation was superior to either intervention alone in enhancing muscle mass, muscle fitness, myokine profiles, and reducing inflammatory markers amon) • PMID:41540398 (2026) — "Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis." (CONCLUSION: Resistance training combined with amino acid supplementation may improve muscle strength and physical function in older adults with sarcopenia, although effects on muscle mass remain limited.)

05

Formulation Selection, Dosing & Chronobiology

Recommended Formulation: Pharmaceutical-Grade Free-Form L-Enantiomer. Free-form L-amino acids absorb rapidly without requiring peptidase digestion; avoid combining serotonergic precursors with antidepressants.

Clinical Trial Dosing & Timing: Published studies most commonly utilize 50 g · 25 g · 5.5g · 2 g over 3 days · 12 months · 4 weeks · 1 weeks. Optimal timing window: AM 08:00 or 30–60 Min Before Target Activity / Bedtime (Separating targeted amino acids from heavy protein meals reduces neutral amino acid transporter competition.).

06

Body Response Monitoring & Dose Adjustment

Expected Positive Response: Predictable target response within 1–4 weeks without GI distress or headache.

Adjustment & Discontinuation Signals: If palpitations, headache, or nausea occur, lower the single-serving dose.

07

Prescription Drug Interactions & Contraindications

No major high-risk prescription contraindications are flagged in the primary index for EAA (Essential Amino Acids), but divalent minerals, fat-soluble compounds, and botanical extracts can still alter absorption or CYP450 metabolism of concurrent medications.

Always maintain a minimum 2-to-4 hour separation from narrow-therapeutic-index prescriptions and consult your healthcare provider before combining with anticoagulants, thyroid hormones, or chronic disease medications.

08

4 Essential Safety Rules Before & After Dosing

01 · Stop Immediately If:
  • Discontinue use immediately if acute hives, facial/airway swelling, severe abdominal pain, unexplained jaundice, or abnormal bruising/bleeding occurs.
  • Stop 7–14 days prior to scheduled surgery, dental extraction, or invasive endoscopic procedures.
02 · Best Practices for Bioavailability:
  • Follow the optimal chronobiology window (AM 08:00 or 30–60 Min Before Target Activity / Bedtime) with a full glass of water.
  • Stay within clinically studied daily dosages (50 g · 25 g · 5.5g) and re-evaluate efficacy after 3 days.
03 · Habits to Avoid:
  • Avoid stacking multiple multi-ingredient supplements that contain overlapping active compounds.
  • Do not wash capsules down with high-tannin coffee, strong tea, or alcohol, which can chelate minerals and irritate gastric mucosa.
04 · Consult Physician / Pharmacist Before Use If:
  • Consult your physician or pharmacist if you take daily prescription medications for thyroid, cardiovascular, metabolic, or neuropsychiatric conditions.
  • Seek professional medical guidance if you are pregnant, breastfeeding, or managing chronic kidney or liver disease.
09 · PUBMED CLINICAL STUDIES

Indexed PubMed Clinical Studies & Abstracts (16 Studies) · 12 Quantitative Analyses

01
CLINICAL STUDY The British journal of nutrition (2016) PMID: 26856623 ↗
Impact of protein-rich meals on glycaemic response of rice.
Clinical Trial Synthesis 2016 Randomized Controlled Trial (RCT) published in The British journal of nutrition. Key conclusion: Therefore, the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre-diabetics to diabetics.
View Original PubMed Abstract ↓

Asians typically consume carbohydrate-rich and high-glycaemic-index diets that have been associated with an increased risk of developing type 2 diabetes. Rice is rarely eaten alone such that it is of interest to investigate the effects of co-ingesting different protein-rich meals with rice on insulin and glycaemic response. This study had a randomised, controlled, non-blind, cross-over design in which fifteen healthy Chinese male participants were required to come on non-consecutive days. Five rice-based test meals were served: rice alone (control), rice with fish (RWF), rice with egg white (RWE), rice with soya beancurd (taukwa) (RWT) and rice with chicken (RWC). The control meal consisted of 50 g of available carbohydrate, whereas all other test meals contained additional 25 g of protein. RWT was the only meal that showed significantly lower glucose response when compared with the control (P<0·05). RWF and RWE had significantly higher insulin response, but no significant increase was observed in RWT and RWC when compared with the control (P<0·05). RWT and RWF showed significantly higher glucagon secretion as compared with the control (P<0·05). The four test meals studied showed varying effects, with RWT showing the greatest reduction in glycaemic response. Therefore, the ingestion of soya beancurd with rice may have a direct impact on reducing the risk in Asians transiting from being pre-diabetics to diabetics.

02
RANDOMIZED TRIAL (RCT) Journal of the International Society of Sports Nutrition (2026) PMID: 41863133 ↗
Combined resistance exercise and essential amino acid intake enhance follistatin/myostatin ratio and muscle fitness in older women: a randomized controlled trial.
Clinical Trial Synthesis 2026 Randomized Controlled Trial (RCT) published in Journal of the International Society of Sports Nutrition; statistical significance reported at p = 0.001. Key conclusion: CONCLUSION: A 12-week intervention combining resistance exercise and essential amino acid supplementation was superior to either intervention alone in enhancing muscle mass, muscle fitness, myokine profiles, and reducing inflammatory markers amon
View Original PubMed Abstract ↓

BACKGROUND: Age-associated sarcopenia and declining physical function in older women are connected to changes in hormones, inflammation, and disrupted protein metabolism. Myokines and cytokines play central roles in muscle atrophy. While both resistance exercise (RE) and essential amino acid (EAA) supplementation are promising interventions, limited randomized trials have assessed their combined effect in healthy elderly populations. Early targeted strategies may help delay sarcopenia and promote healthier aging. METHODS: A 12-week randomized controlled trial was performed involving 96 healthy women aged ≥ 65 years without insulin resistance. Participants were randomized into four groups: control, RE, EAA, or RE + EAA. The intervention consisted of a circuit-based training program conducted three times per week, with each session lasting 60 minutes at moderate intensity. Participants in EAA and RE + EAA groups consumed 5.5g of EAA twice daily. Assessments before and after the intervention included body composition, muscle fitness, serum myokines, and inflammatory cytokines. Data analysis involved two-way repeated measures ANOVA, Bonferroni post-hoc comparisons, and one-way ANOVA for changes in the follistatin/myostatin ratio. RESULTS: The RE + EAA group demonstrated a significant increase in muscle mass (F(3, 72) = 5.042, p < 0.001, partial η² = 0.174) and greater improvements in the senior fitness test (p ranging from < 0.05 to < 0.001). There was a reduction in myostatin levels (p < 0.05) and an elevation in follistatin in both the RE (p < 0.05) and RE + EAA (p < 0.001) groups. The follistatin/myostatin ratio increased most in the RE + EAA group (F(3, 72) = 5.556, p = 0.002, partial η² = 0.188), with significance versus control (p < 0.001), EAA (p < 0.05) groups. IL-6 and IL-1β were significantly reduced in the RE (p < 0.05) and RE + EAA (p < 0.05) groups, whereas TNF-α decreased only in the RE + EAA group (p < 0.05). CONCLUSION: A 12-week intervention combining resistance exercise and essential amino acid supplementation was superior to either intervention alone in enhancing muscle mass, muscle fitness, myokine profiles, and reducing inflammatory markers amon

03
META-ANALYSIS BMC musculoskeletal disorders (2026) PMID: 41540398 ↗
Combined resistance training and amino acid-based supplementation for sarcopenia in older adults: a systematic review and meta-analysis.
Clinical Trial Synthesis 2026 Meta-Analysis published in BMC musculoskeletal disorders involving n = 496 participants (SMD 0.69). Key conclusion: CONCLUSION: Resistance training combined with amino acid supplementation may improve muscle strength and physical function in older adults with sarcopenia, although effects on muscle mass remain limited.
View Original PubMed Abstract ↓

BACKGROUND AND OBJECTIVE: Resistance training is the cornerstone of sarcopenia management. However, whether combining it with amino acid-based supplementation, including essential amino acids, branched-chain amino acids, leucine, and derivatives such as HMB, provides additional benefits remains unclear. METHODS: We systematically searched PubMed, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials until February 2025. Meta- and subgroup analyses were performed using a random-effects model. The Cochrane ROB2 tool and GRADE framework were used to assess the risk of bias and evidence certainty. RESULTS: We included nine randomized controlled trials involving 496 participants with sarcopenia. Evidence rated as low to very low certainty indicated that, compared with resistance training alone, combined amino acid supplementation and resistance training significantly improved handgrip strength (SMD = 0.69, 95% CI: 0.04 to 1.35), gait speed (SMD = 0.64, 95% CI: 0.02 to 1.25), Short Physical Performance Battery scores (SMD = 1.69, 95% CI: 0.81 to 2.57), and Five Times Sit-to-Stand Test performance (SMD = -1.42, 95% CI: -2.68 to -0.16). No significant effects were observed for skeletal muscle mass index or appendicular skeletal muscle mass. Subgroup analyses showed that baseline protein intake, intervention setting, amino acid supplement type, resistance-training frequency, and whether the supplement contained co-nutrients were significant effect modifiers. CONCLUSION: Resistance training combined with amino acid supplementation may improve muscle strength and physical function in older adults with sarcopenia, although effects on muscle mass remain limited. Responsiveness to the intervention may vary by baseline protein intake, training frequency, setting, type of amino acid supplementation, and whether the supplement includes co-nutrients, all of which should be considered when designing sarcopenia management strategies. © 2026. The Author(s).

04
CLINICAL STUDY Journal of the International Society of Sports Nutrition (2025) PMID: 41321015 ↗
Dileucine-supplemented essential amino acids support whole-body anabolism after resistance exercise and serum-stimulated cell-based anabolism.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Journal of the International Society of Sports Nutrition; statistical significance reported at p = 0.68. Key conclusion: RESULTS: Total exogenous leucine retention were similar (p = 0.68) between DIEAA (215.72 ± 42.45 μmol·kg-1) and BCAA conditions (219.15 ± 45.26 μmol·kg-1), with both DIEAA and BCAA being greater (p < 0.0001) than COL (37.25 ±
View Original PubMed Abstract ↓

BACKGROUND: Essential (EAA) and branched chain (BCAA) amino acid ingestion support whole-body anabolism after resistance exercise and can attenuate markers of postexercise myofibrillar protein breakdown (i.e. urinary 3-methylhistidine; 3MH). Leucine is often considered a primary anabolic EAA through its ability to activate the mechanistic target of rapamycin complex 1 (mTORC1) and stimulate muscle protein synthesis. The dipeptide leucine (dileucine) has been shown to more effectively stimulate myofibrillar protein synthesis than leucine in young males at rest. Therefore, we aimed to determine the effect of a dileucine-containing essential amino acid formula (DIEAA; 2 g dileucine, 1 g leucine, 9.15 g total EAA) on the anabolic and catabolic responses following resistance exercise in young recreationally active adults when compared with ingesting branched chain amino acids (BCAA; 3 g leucine, 1.5 g isoleucine, 1.5 g valine) or isonitrogenous (to DIEAA) collagen hydrolysate (COL). METHODS: In a randomized, double-blind, crossover design, 12 healthy adults (8 M, 4F, aged 24 ± 3 y) performed a 60 min bout of whole-body resistance exercise, after which they ingested DIEAA, BCAA, or COL protein beverages containing 100 mg L-[1-13C]leucine (#NCT05754125). Total exogenous leucine retention (as an estimate of whole-body anabolism) was assessed over the 6 h postprandial period by determining total leucine oxidation from 13CO2 enrichment (isotope ratio mass spectrometry) in repeated breath samples. A urinary 3MH:creatinine ratio (3MH:Cr) over 6 h was used as an estimate of skeletal muscle myofibrillar protein breakdown. To further assess the anabolic potential of nutrients, C2C12 myotubes were treated with a subset (n = 7) of human serum-conditioned media for 4 h to measure downstream mTORC1 substrate phosphorylation, protein synthesis (puromycin and L-ring-[D5]phenylalanine incorporation) and breakdown (ubiquitinated protein), and myotube hypertrophy. RESULTS: Total exogenous leucine retention were similar (p = 0.68) between DIEAA (215.72 ± 42.45 μmol·kg-1) and BCAA conditions (219.15 ± 45.26 μmol·kg-1), with both DIEAA and BCAA being greater (p < 0.0001) than COL (37.25 ±

05
CLINICAL STUDY Nutrients (2025) PMID: 41228483 ↗
The Effect of Leucine-Enriched β-Lactoglobulin Versus an Isonitrogenous Whey Protein Isolate on Skeletal Muscle Protein Anabolism in Young Healthy Males.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Nutrients; statistical significance reported at p = 0.05. Key conclusion: CONCLUSIONS: Both BLG and WPI effectively stimulated MPS doses in young healthy males, with BLG offering an advantage in EAA/BCAA/LEU bioavailability.
View Original PubMed Abstract ↓

BACKGROUND: β-lactoglobulin (BLG) is a protein found within whey protein (WP) that is rich in essential amino acids, most notably, leucine (LEU). LEU is considered the most potent EAA in the postprandial stimulation of muscle protein synthesis (MPS), such that suboptimal protein/essential amino acid (EAA) doses containing higher LEU content elicit muscle anabolism comparable to larger protein doses. Our objective was to test the effects of naturally LEU-rich BLG (~10 g protein) versus isonitrogenous whey protein isolate (WPI, ~10 g) on MPS. METHODS: Ten healthy young men (26 ± 2 y; 179 ± 2 cm; 81 ± 3 kg) received BLG (1.57 g LEU) or WPI (1.02 g LEU) in a randomised double-blind cross-over fashion. A primed constant intravenous infusion of [1,2 13C2] LEU was used to determine MPS (isotope ratio mass spectrometry) at baseline and in response to feeding (FED) and feeding-plus-exercise (FED-EX; 6 × 8 unilateral leg extensions; 75% 1-RM). Plasma insulin and EAA's were quantified. RESULTS: Plasma EAA, branched-chain amino acid (BCAA), and LEU concentrations increased rapidly following both protein supplements but exhibited a significantly greater EAA/BCAA/leucinemia following BLG (p < 0.05 for all). MPS increased significantly in both FED (~52%) and FED-EX (~58%) states, with no significant differences between supplements. CONCLUSIONS: Both BLG and WPI effectively stimulated MPS doses in young healthy males, with BLG offering an advantage in EAA/BCAA/LEU bioavailability. It follows that future research should explore the potential of BLG in populations exhibiting anabolic resistance and exercise anabolism deficiency, such as older adults as well as frail and clinical populations, to assess its utility in preserving muscle mass under conditions of suboptimal protein intake.

06
CLINICAL STUDY Nutrients (2025) PMID: 40573107 ↗
Effects of Pork Protein Ingestion Prior to and Following Performing the Army Combat Fitness Test on Markers of Catabolism, Inflammation, and Recovery.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Nutrients involving n = 23 participants. Key conclusion: There was also evidence of more favorable changes in red and white blood cells.
View Original PubMed Abstract ↓

Tactical athletes and military personnel engaged in intense exercise need to consume enough quality protein in their diet to maintain protein balance and promote recovery. Plant-based protein sources contain fewer essential amino acids (EAAs), while pork loin contains a higher concentration of EAAs and creatine than most other animal protein sources. This study aimed to determine whether the ingestion of plant-based or pork-based military-style meals ready-to-eat (MREs) affects recovery from and subsequent Army Combat Fitness Test (ACFT) performance. Methods: Twenty-three (n = 23) University Corps of Cadets members participated in a randomized, double-blind, placebo-controlled, and crossover-designed study. Diets were prepared by a dietitian, food scientist, and chef to have similar taste, appearance, texture, and macronutrient content. The chef also labeled the meals for double-blind administration. Participants refrained from intense exercise for 48 h before reporting to the lab in a fasted condition with a 24 h urine sample. Participants donated a blood sample, completed questionnaires and cognitive function tests, and consumed a pre-exercise meal. After four hours, participants performed the ACFT according to military standards. Participants were fed three MREs daily while returning to the lab in a fasted condition at 0600 with 24 h urine samples after 24, 48, and 72 h of recovery. On day 3, participants repeated the ACFT four hours after consuming an MRE for breakfast. Participants resumed normal training and returned to the lab after 2-3 weeks to repeat the experiment while consuming the alternate diet. Data were analyzed using general linear model statistics with repeated measures and percent changes from baseline with 95% confidence intervals. Results: Results revealed that 3 days were sufficient for participants to replicate ACFT performance. However, those consuming the pork-based diet experienced less muscle soreness, urinary urea excretion, cortisol, inflammation, and depression scores while experiencing a higher testosterone/cortisol ratio and appetite satisfaction. There was also evidence of more favorable changes in red and white blood cells. Conv

07
CLINICAL STUDY Nutrients (2024) PMID: 39683547 ↗
Nutritional Management in Stricturing Crohn's Disease: A Pilot Study.
Clinical Trial Synthesis 2024 Randomized Controlled Trial (RCT) published in Nutrients; statistical significance reported at p = 0.01. Key conclusion: CONCLUSIONS: Further prospective studies are needed to confirm these results; nonetheless this nutritional approach could become an integral part in the treatment of stricturing CD patients to improve disease outcomes and increase the quality of life in these patients.
View Original PubMed Abstract ↓

BACKGROUND: More than half of patients with Crohn's disease develop intestinal fibrosis induced intestinal obstruction with debilitating symptoms throughout their disease course. The incidence of stricture formation in CD has remained unchanged over the last several decades. Factors promoting intestinal fibrosis are currently unclear, but diet may represent an underestimated risk factor for intestinal fibrosis by modification of both the host immune response and intestinal microbial composition. Evaluating the impact of diet on the course of IBD is very complex. Sarcopenia is a common problem in IBD patients and correlates with an increased rate of disease. Skeletal muscle index (SMI) is an important parameter to measure sarcopenia and is an easily accessible tool for evaluating the likelihood of complications in individuals with CD. METHODS: Using a randomized and controlled pilot design, we aimed to investigate the efficacy of 12 months of short-term dietary intervention based on essential amino acid (EAA) and sodium butyrate (NaB) supplementation in the management of stricturing Crohn's disease patients. RESULTS: After the treatment in the diet EAA/NaB group, we revealed a statistically significant improvement of muscle mass (61.49 ± 5.47 vs. control 86 ± 10.70, p = 0.01) and SMI index (9.97 ± 1.79 vs. control 7.60 ± 2.29, p = 0.02). In addition, the measurement of skeletal muscle mass in CD patients has been suggested to be crucial for predicting the disease course. Indeed, after one year, surgery was required in 4/10 control group patients (40%) and 1/10 study group (10%) patients, underlining the importance of body composition alterations and adequate dietary intake in the management of these patients. CONCLUSIONS: Further prospective studies are needed to confirm these results; nonetheless this nutritional approach could become an integral part in the treatment of stricturing CD patients to improve disease outcomes and increase the quality of life in these patients.

08
CLINICAL STUDY Medicine and science in sports and exercise (2025) PMID: 39160756 ↗
Consuming Whey Protein with Added Essential Amino Acids, Not Carbohydrate, Maintains Postexercise Anabolism While Underfed.
Clinical Trial Synthesis 2025 Randomized Controlled Trial (RCT) published in Medicine and science in sports and exercise; statistical significance reported at p = 0.015. Key conclusion: CONCLUSIONS: These data suggest that supplementing EAA-enriched whey protein with more energy as EAA, not carbohydrate, maintains postexercise MPS during energy deficit at rates comparable to those observed during energy balance.
View Original PubMed Abstract ↓

PURPOSE: Energy deficiency decreases muscle protein synthesis (MPS), possibly due to greater whole-body essential amino acid (EAA) requirements and reliance on energy stores. Whether energy deficit-induced anabolic resistance is overcome with non-nitrogenous supplemental energy or if increased energy as EAA is needed is unclear. We tested the effects of energy as EAA or carbohydrate, combined with an EAA-enriched whey protein, on postexercise MPS (%·h -1 ) and whole-body protein turnover (g protein·240 min -1 ). METHODS: Seventeen adults (mean ± SD; age: 26 ± 6 yr, body mass index: 25 ± 3 kg·m -2 ) completed a randomized, parallel study including two 5-d energy conditions (BAL; energy balance; daily energy requirements (DEF), -30% ± 3% energy requirements) separated by ≥7 d. Volunteers consumed EAA-enriched whey with added EAA (+EAA; 304 kcal, 56 g protein, 48 g EAA, 17 g carbohydrate, 2 g fat; n = 8) or added carbohydrate (+CHO; 311 kcal, 34 g protein, 24 g EAA, 40 g carbohydrate, 2 g fat; n = 9) following exercise. MPS and whole-body protein synthesis (PS), breakdown (PB), and net balance (NET; PS-PB) were estimated postexercise with isotope kinetics. RESULTS: MPS rates were greater in +EAA (0.083 ± 0.02) than +CHO (0.059 ± 0.01; P = 0.015) during daily energy requirements, but similar during BAL ( P = 0.45) and across energy conditions within treatments ( P = 0.056). PS rates were greater for +EAA (BAL, 117.9 ± 16.5; daily energy requirements, 110.3 ± 14.8) than +CHO (BAL, 81.6 ± 8.0; daily energy requirements, 83.8 ± 5.9 g protein·240 min -1 ; both P < 0.001) and greater during BAL than daily energy requirements in +EAA ( P = 0.045). PB rates were less in +EAA (8.0 ± 16.5) than +CHO (37.8 ± 7.6 g protein·240 min -1 ; P < 0.001), and NET was greater in +EAA (106.1 ± 6.3) than +CHO (44.8 ± 8.5 g protein·240 min -1 ; P < 0.001). CONCLUSIONS: These data suggest that supplementing EAA-enriched whey protein with more energy as EAA, not carbohydrate, maintains postexercise MPS during energy deficit at rates comparable to those observed during energy balance.

09
CLINICAL STUDY Nutrients (2024) PMID: 38892621 ↗
Effects of Resistance Exercise and Essential Amino Acid Intake on Muscle Quality, Myokine, and Inflammation Factors in Young Adult Males.
Clinical Trial Synthesis 2024 Clinical Study published in Nutrients. Key conclusion: CONCLUSIONS: RE, EAA, and RE + EAA could effectively improve the muscle quality, myokine, and inflammation factors of young adult males.
View Original PubMed Abstract ↓

BACKGROUND: Recently, many studies have been devoted to discovering nutrients for exercise-like effects. Resistance exercise and the intake of essential amino acids (EAAs) are known to be factors that can affect muscle mass and strength improvement. The purpose of this study was to investigate changes in muscle quality, myokines, and inflammation in response to resistance exercise and EAA supplementation. METHODS: Thirty-four males volunteered to participate in this study. They were assigned to four groups: (1) placebo (CO), (2) resistance exercise (RE), (3) EAA supplementation, and (4) RE + EAA supplementation. Body composition, muscle quality, myokines, and inflammation were measured at baseline and four weeks after treatment. RESULTS: Lean body fat had decreased in both RE and RE + EAA groups. Lean body mass had increased in only the RE + EAA group. In all groups except for CO, irisin, myostatin A, and TNF-α levels had decreased. The grip strength of the right hand and trunk flexion peak torque increased in the RE group. The grip strength of the left hand, trunk flexion peak torque, and knee flexion peak torque of the left leg were increased in RE + EAA. CONCLUSIONS: RE, EAA, and RE + EAA could effectively improve the muscle quality, myokine, and inflammation factors of young adult males. This finding highlights the importance of resistance exercise and amino acid intake.

10
RANDOMIZED TRIAL (RCT) The Journal of nutrition (2024) PMID: 38467279 ↗
Acute Microbial Protease Supplementation Increases Net Postprandial Plasma Amino Acid Concentrations After Pea Protein Ingestion in Healthy Adults: A Randomized, Double-Blind, Placebo-Controlled Trial.
Clinical Trial Synthesis 2024 Randomized Controlled Trial (RCT) published in The Journal of nutrition; statistical significance reported at p = 0.001. Key conclusion: CONCLUSIONS: Microbial protease co-ingestion increases plasma TAA concentrations (0-5 h) and leucine, BCAA, EAA, and TAA availability in the early postprandial period (0‒2 h) compared with ingesting pea protein with placebo in healthy adults.
View Original PubMed Abstract ↓

BACKGROUND: Digestibility is a primary factor in determining the quality of dietary protein. Microbial protease supplementation may be a strategy for improving protein digestion and subsequent postprandial plasma amino acid availability. OBJECTIVES: To assess the effect of co-ingesting a microbial protease mixture with pea protein on postprandial plasma amino acid concentrations. DESIGN: A mixture of 3 microbial protease preparations (P3) was tested for proteolytic efficacy in an in vitro static simulation of gastrointestinal digestion. Subsequently, in a randomized, double-blind, placebo-controlled crossover trial, 24 healthy adults (27 ± 4 y; 12 females, 12 males) ingested 25 g pea protein isolate (20 g protein, 2.2 g fat) with either P3 or maltodextrin placebo (PLA). Blood samples were collected at baseline and throughout a 0‒5 h postprandial period and both the early (0-2 h) iAUC and total (0-5 h) iAUC were examined. RESULTS: Plasma glucose concentrations decreased in both conditions (P < 0.001), with higher concentrations after P3 ingestion compared with PLA (P < 0.001). Plasma insulin concentrations increased for both conditions (P < 0.001) with no difference between conditions (P = 0.331). Plasma total amino acid (TAA) concentrations increased over time (P < 0.001) with higher concentrations observed for P3 compared with PLA (P = 0.010) during the 0‒5 h period. There was a trend for elevated essential amino acid (EAA) concentrations for P3 compared with PLA (P = 0.099) during the 0‒5 h postprandial period but not for leucine (P = 0.282) or branched-chain amino acids (BCAA, P = 0.410). The early net exposure (0‒2 h iAUC) to amino acids (leucine, BCAA, EAA, and TAA) was higher for P3 compared with PLA (all, P < 0.05). CONCLUSIONS: Microbial protease co-ingestion increases plasma TAA concentrations (0-5 h) and leucine, BCAA, EAA, and TAA availability in the early postprandial period (0‒2 h) compared with ingesting pea protein with placebo in healthy adults.

RELATED MONOGRAPHS

Related Monographs in This Category